Search

everythinglearnresearchcommunity

for

Search:↓

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

A vitamin D3 compound can reduce skin cell growth.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

The method identified and measured ten compounds from Eclipta prostrata, showing significant enzyme inhibitory effects.

PPCM microspheres can effectively release finasteride over 42 days.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Polydopamine and quercetin together can speed up hair regrowth.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.